Evidence map›Paper›PMID 37953925›Full record

ArticleFrontiers in clinical diabetes and healthcare2023

Factors associated with chronic kidney disease in patients with diabetes in French Guiana.

Christopher Sacareau, Mathieu Nacher, Kinan Drak Alsibai, Andre Ntoutoum, Antoine Adenis, Marianne Hounnou, Marion Liebart, Clara Salasar Cardoso, Jean-Markens Aurelus, Magalie Demar and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in clinical diabetes and healthcare, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Christopher SacareauDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
Mathieu NacherClinical Investigation Center Antilles French Guiana (CIC INSERM 1424), Cayenne Hospital Center, Cayenne, French Guiana.
Kinan Drak AlsibaiClinical Investigation Center Antilles French Guiana (CIC INSERM 1424), Cayenne Hospital Center, Cayenne, French Guiana.
Andre NtoutoumDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
Antoine AdenisClinical Investigation Center Antilles French Guiana (CIC INSERM 1424), Cayenne Hospital Center, Cayenne, French Guiana.
Marianne HounnouDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
Marion LiebartDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
Clara Salasar CardosoClinical Investigation Center Antilles French Guiana (CIC INSERM 1424), Cayenne Hospital Center, Cayenne, French Guiana.
Jean-Markens AurelusDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
Magalie DemarLaboratory of Parasitology-Mycology, Cayenne Hospital Center, Cayenne, French Guiana.
Olivier CasseClinical Investigation Center Antilles French Guiana (CIC INSERM 1424), Cayenne Hospital Center, Cayenne, French Guiana.
Samia AmokraneDepartment of Medicine, Ouest Guyane Hospital Center, Saint-Laurent, French Guiana.
Jean-François CarodLaboratory of Biology, Ouest Guyane Hospital Center, Saint-Laurent, French Guiana.
Nezha HafsiDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
Nadia SabbahDepartment of Endocrinology and Metabolic Diseases, Cayenne Hospital Center, Cayenne, French Guiana.
University of French Guiana · GF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: With over half of the population living under the poverty threshold, the social and health context in French Guiana is more difficult than in mainland France. The prevalence of diabetes is twice as great and end-stage renal failure is 45% higher than in mainland France. Objective: Our objective was to describe the profile of diabetic patients with chronic kidney disease in French Guiana and search for possible risk factors. Method: We conducted a multicenter cross-sectional observational study based on the CODIAM cohort (Cohort of Diabetes in French Amazonia). We analyzed 1,287 patients followed up between May 2019 and June 2021 at Cayenne Hospital, Saint Laurent Hospital, and delocalized health centers. Results: In our cohort, chronic kidney disease was present after an average of 12 years of diabetes. Compared with the French population, 41% of diabetic patients had chronic kidney disease (i.e., 12% more), and had an average age of 56 years (i.e., 10 years younger). Forty-eight per cent of these patients were obese (i.e., 7% more). Seventy-four per cent of patients were precarious and 45% were foreigners but neither was associated with chronic kidney disease, contrary to countries where the health system is not universal. Conclusion: Screening of patients with chronic kidney disease among diabetics in French Guiana remains a real challenge. Patients were younger and more obese than in other French territories. In this cohort, precariousness and immigration were not associated with the presence of chronic kidney disease. However, particular attention should be paid to hypertensive patients and those over 65 years of age, which are, with diabetes itself, the two most obvious risk factors for developing chronic kidney disease among diabetic patients in our territory.

Indexed as

diabetes complicationsdiabetes mellitusFrench Guianakidney diseasepatient cohort

Identifiers

PMID37953925
PMCPMC10634610
OpenAlexW4387959179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.